| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH.
|
Proc Natl Acad Sci U S A
|
2012
|
1.68
|
|
2
|
T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling.
|
Cell Metab
|
2009
|
1.32
|
|
3
|
Effects of thyroid hormone on A1C and glycated albumin levels in nondiabetic subjects with overt hypothyroidism.
|
Diabetes Care
|
2010
|
1.13
|
|
4
|
Transitional CpG methylation between promoters and retroelements of tissue-specific genes during human mesenchymal cell differentiation.
|
J Cell Biochem
|
2007
|
1.06
|
|
5
|
Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
|
J Bone Miner Metab
|
2004
|
0.95
|
|
6
|
Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals.
|
Endocr J
|
2010
|
0.94
|
|
7
|
Relationship between vitamin D, parathyroid hormone, and bone mineral density in elderly Koreans.
|
J Korean Med Sci
|
2012
|
0.92
|
|
8
|
The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
|
Am J Obstet Gynecol
|
2005
|
0.88
|
|
9
|
Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma.
|
Thyroid
|
2007
|
0.88
|
|
10
|
The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women.
|
Exp Mol Med
|
2007
|
0.88
|
|
11
|
Visceral obesity is a negative predictor of remission of diabetes 1 year after bariatric surgery.
|
Obesity (Silver Spring)
|
2011
|
0.88
|
|
12
|
The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
|
Diabetes Metab Res Rev
|
2012
|
0.86
|
|
13
|
Serum BMP-4 levels in relation to arterial stiffness and carotid atherosclerosis in patients with Type 2 diabetes.
|
Biomark Med
|
2011
|
0.85
|
|
14
|
The relationship between Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women.
|
Endocr J
|
2010
|
0.83
|
|
15
|
Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
|
Thyroid
|
2013
|
0.83
|
|
16
|
Visceral obesity is a better predictor than generalized obesity for basal insulin requirement at the initiation of insulin therapy in patients with type 2 diabetes.
|
Diabetes Res Clin Pract
|
2011
|
0.82
|
|
17
|
Long-term effects of rosiglitazone on the progressive decline in renal function in patients with type 2 diabetes.
|
Korean J Intern Med
|
2009
|
0.82
|
|
18
|
Diabetic retinopathy is associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus.
|
Diabetes Res Clin Pract
|
2010
|
0.81
|
|
19
|
Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein.
|
Clin Sci (Lond)
|
2005
|
0.81
|
|
20
|
A novel splice site mutation of the arginine vasopressin-neurophysin II gene identified in a kindred with autosomal dominant familial neurohypophyseal diabetes insipidus.
|
Mol Genet Metab
|
2005
|
0.80
|
|
21
|
Usefulness of albuminuria as predictor for coronary artery stenosis, regardless of estimated glomerular filtration rate, in patients with type 2 diabetes mellitus.
|
Am J Cardiol
|
2012
|
0.79
|
|
22
|
Combination of initial stimulation thyroglobulins and staging system by revised ATA guidelines can elaborately discriminate prognosis of patients with differentiated thyroid carcinoma after high-dose remnant ablation.
|
Clin Nucl Med
|
2012
|
0.78
|
|
23
|
Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
|
Thyroid
|
2012
|
0.77
|
|
24
|
Changes in serum levels of bone morphogenic protein 4 and inflammatory cytokines after bariatric surgery in severely obese korean patients with type 2 diabetes.
|
Int J Endocrinol
|
2013
|
0.76
|
|
25
|
Serum Bone Morphogenic Protein-4 Contributes to Discriminating Coronary Artery Disease Severity.
|
Medicine (Baltimore)
|
2015
|
0.75
|